supported by the Guangdong Natural Science Foundation for Distinguished Young Scholar(2020B1515020003);Shenzhen Science and Technology Program KQTD20200909113758004;China Postdoctoral Science Foundation(2020M672649);National Natural Science Foundation of China(91951204 and 32200155);Guangdong Basic and Applied Basic Research Foundation(2019A1515110640 and 2020A1515010316).
Pseudomonas aeruginosa is one of the leading nosocomial pathogens that causes both severe acute and chronic infections.The strong capacity of P.aeruginosa to form biofilms can dramatically increase its antibiotic resi...
The quality system of any modern pharmaceutical company is the pharmaceutical quality system(PQS),which extends the GMP standards to all stages of the medicinal productslife cycle,from pharmaceutical development to it...
This work was funded by the Biomedical Research Council, Agency for Science, Technology and Research (A'STAR), Singapore, and by the National Natural Science Foundation of China (Grant No. 31330002). We apologize to the scientists who made contributionsto the field, but their works have not been cited due to space limitations.
Pseudomonas aeruginosa causes severe and persistent infections in immune compromised individuals and cystic fibrosis sufferers. The infection is hard to eradi- cate as P. aeruginosa has developed strong resistance to ...